Engagement of the CD3/T cell antigen receptor complex on small, resting T cells is insufficient to trigger cell-mediated cytotoxicity or to induce a proliferative response. In the present study, we have used genetic transfection to demonstrate that interaction of the B7-BB1 B cell activation antigen with the CD28 T cell differentiation antigen costimulates cell-mediated cytotoxicity and proliferation initiated by either anti-CD2 or anti-CD3 monoclonal antibody (mAb). Moreover, a B7-negative Burkitt's lymphoma cell line that fails to stimulate an allogeneic mixed lymphocyte response is rendered a potent stimulator after transfection with B7. The mixed leukocyte reaction proliferative response against the B7 transfectant is inhibited by either anti-CD28 or B7 mAb. We also demonstrate that freshly isolated small, resting human T cells can mediate anti-CD3 or anti-CD2 mAb-redirected cytotoxicity against a murine Fc receptor-bearing mastocytoma transfected with human B7. These preexisting cytotoxic T lymphocytes in peripheral blood are present in both the CD4 and CD8 subsets, but are preferentially within the CD45RO + "memory" population. While small, resting T cells apparently require costimulation by CD28/B7 interactions, this requirement is lost after T cell activation. Anti-CD3 initiates a cytotoxic response mediated by in vitro cultured T cell clones in the absence of B7 ligand. The existence of functional cytolytic T cells in the small, resting T cell population may be advantageous in facilitating rapid responses to immune challenge. CD28 is a disulfide-linked homodimer that is expressed on the majority of human peripheral blood T cells (6, 7). mAbs against CD28 in conjunction with phorbol ester induce T cell proliferation (7) and augment proliferation induced by anti-CD3 or anti-CD2 mAb (8-12). Anti-CD28 mAb-induced proliferation is IL-2 dependent (7, 8) and possibly results from stabilization of messenger RNA for IL-2 and other cytokines (13).
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Engagement of the CD3/T cell antigen receptor complex on small, resting T cells is insufficient to trigger cell-mediated cytotoxicity or to induce a proliferative response. In the present study, we have used genetic transfection to demonstrate that interaction of the B7-BB1 B cell activation antigen with the CD28 T cell differentiation antigen costimulates cell-mediated cytotoxicity and proliferation initiated by either anti-CD2 or anti-CD3 monoclonal antibody (mAb). Moreover, a B7-negative Burkitt's lymphoma cell line that fails to stimulate an allogeneic mixed lymphocyte response is rendered a potent stimulator after transfection with B7. The mixed leukocyte reaction proliferative response against the B7 transfectant is inhibited by either anti-CD28 or B7 mAb. We also demonstrate that freshly isolated small, resting human T cells can mediate anti-CD3 or anti-CD2 mAb-redirected cytotoxicity against a murine Fc receptor-bearing mastocytoma transfected with human B7. These preexisting cytotoxic T lymphocytes in peripheral blood are present in both the CD4 and CD8 subsets, but are preferentially within the CD45RO + "memory" population. While small, resting T cells apparently require costimulation by CD28/B7 interactions, this requirement is lost after T cell activation. Anti-CD3 initiates a cytotoxic response mediated by in vitro cultured T cell clones in the absence of B7 ligand. The existence of functional cytolytic T cells in the small, resting T cell population may be advantageous in facilitating rapid responses to immune challenge.
T lymphocytes recognize antigen via the CD3/TCR complex. Binding of anti-CD3 or anti-TCR mAb to T cells results in a rapid increase in intracellular [Ca 2+ ] and the generation of inositol triphosphate (IP3) (1) (2) (3) (4) . Although crosslinking of CD3/TCR alone is often sufficient to induce inositolphosphate pathway activation, other signals are apparently necessary to induce functions such as cytokine secretion and proliferation (4) . Both soluble factors and interaction with cell surface receptors have been implicated as costimulators of CD3/TCR-mediated activation. For example, allo-antigen-specific helper T cells fail to produce cytokines in response to HLA-DR7 antigen expressed in murine L cells. However, cotransfection of HLA-DR7 and CD54 (intracellular adhesion molecule I [ICAM-1]), a cellular ligand for CDll/18 leukocyte function-associated molecule 1 [LFA-1]), restores T cell responsiveness (5) . Thus, antigen-specific recognition alone may be insufficient to trigger effector functions since additional accessory molecules are required for an efficient response.
CD28 is a disulfide-linked homodimer that is expressed on the majority of human peripheral blood T cells (6, 7) . mAbs against CD28 in conjunction with phorbol ester induce T cell proliferation (7) and augment proliferation induced by anti-CD3 or anti-CD2 mAb (8) (9) (10) (11) (12) . Anti-CD28 mAb-induced proliferation is IL-2 dependent (7, 8) and possibly results from stabilization of messenger RNA for IL-2 and other cytokines (13) .
Recently, it has been demonstrated that a B cell activation antigen, B7 (14) or BB1 (15) , is a natural ligand for CD28 and that this receptor/ligand interaction mediates heterotypic adhesion (16) . Interaction of CD28 and B7 results in augmentation of T cell proliferation and cytokine production, and antibodies against CD28 or B7 inhibit alloantigen and mitogen-induced proliferative responses (16, 17) . B7 is weakly expressed on resting B cells and monocytes, and is elevated after stimulation with pokeweed mitogen, anti-Ig, anti-HLA class II, and EBV (14, 15, 17) . Therefore, it is likely that T cell activation via CD28 will depend on the capacity of the APC to upregulate expression of B7. The importance of the CD28/B7 interaction in polyclonal mitogenic responses prompted us to investigate whether the binding orB7 to CD28
costimulates the generation of a proliferative response against alloantigen and can augment the generation of T cell-mediated cytotoxicity in small, resting T lymphocytes.
Materials and Methods
Preparation of TLyraphocytes. Human peripheral blood was obtained from the Stanford Blood Center (Palo Alto, CA). Mononuclear cells were isolated by density gradient centrifugation using Ficoll/Hypaque. Monocytes and B cells were depleted by plastic adherence and passage through nylon wool columns (18) . Nonadherent lymphocytes were fractionated by centrifugation on discontinuous gradients consisting of 30% and 40% Percoll (Pharmacia Fine Chemicals, Piscataway, NJ) in PBS containing 10% FCS (18) . High buoyant density lymphocytes enriched for small, resting T cells were isolated from the bottom of the Percoll gradients. Thymocytes from 1-yr-old children undergoing cardiac surgery were obtained from Stanford Medical Center (Palo Alto, CA). The biopsies were minced with scissors, the single cell suspension was passed through a nylon mesh, and mononudear cells were isolated by Ficoll/Hypaque density centrifugation. Umbilical cord blood was collected from healthy full-term neonates immediately after vaginal delivery. High buoyant density cord blood CD3 + T lymphocytes were obtained as for peripheral blood.
T Cell Clones. T cell clones were established from normal PBL or fetal liver, as described (19) . The following dones were used: mAbs. BB1 mAb (15) was generously provided by Dr. Ed Clark (University of Washington, Seattle, WA). L293 is a murine IgG1 mAb directed against CD28 that was generated by immunizing BALB/c mice with the HPB-ALL T cell line and fusing immune splenocytes with Sp2/0 myeloma cells. L303 (IgG2a, g) and L304 (IgG1, g) are murine mAbs directed against CD2 and CD2R, respectively, that were generated by immunizing BALB/c mice with anti-CD3-activated PBL and fusing immune splenocytes with Sp2/0 myeloma cells. Other mAbs were generously provided by Becton Dickinson Immunocytometry Systems (San Jose, CA). F(ab')2 fragments of anti-CD3, CD28 and CD16 mAbs (all IgG1 isotype) were prepared using immobilized pepsin (Pierce Chemical Co., Rockford, IL). Purity of F(ab')2 fragments was verified by SDS-PAGE analysis.
Transfection. P815, a murine mastocytoma cell line, and Ramos, a human Burkitt's lymphoma cell line, were obtained from American Type Culture Collection (Rockville, MD). Human B7 cDNA (generously provided by Dr. J. Allison, University of California, Berkeley) was subcloned into the pBJ expression vector (20) . 107 P815 and Ramos cells were transfected with 15 #g pBJ/B7 plasmid by electroporation (2.0 KV, 25/tFD) using a Gene Pulser (Bio-Rad Laboratories, Richmond, CA) and selected in culture medium (ILPMI 1640 [M. A. Bioproducts, Walkersville, MD] + 10% FCS [JR Scientific, Woodland, CA], 1 mM sodium pyruvate, 1 mM L-glutamine, 1% penicillin-streptomycin) supplemented with 2 mg/ml G418 (Gibco Laboratories, Grand Island, NY). After drug selection, B7-transfected P815 and Ramos cells were cloned and selected for high cell surface B7 expression by flow cytometry. Transfectants were maintained in culture medium containing 1 mg/ml G418.
Anti-CD3-induced Redirected Cytotoxicity Assays. Cytotoxicity was measured in a 4-h S~Cr-release assay (18) . Anti-CD3 or anti-CD2 mAbs were added to SlCr-labeled P815 or B7 § P815 target cells 30 min before addition of effector T cells, unless indicated otherwise. In mAb blocking studies, all mAbs were used at a final concentration of 5 #g/ml and were added at initiation of the assay.
Proliferation Assays. Irradiated (80 Gy) P815 and B7 § P815 (3 x 104 cells/well) were plated with anti-CD3 (anti-Leu-4; 5 /tg/ml) or anti-CD2 (L303 and L304, 1.25 #g/ml) mAbs in flatbottomed 96-well microtiter plates (Falcon Labware, Lincoln Park, NJ). After incubation for 30 min at room temperature, high buoyant density T cells were added at 105 cells/well. Cultures were incubated at 37~ with 5% CO2 in a humidified atmosphere for 72 h. For the mixed lymphocyte response, 105 high buoyant density T cells and 104 irradiated (80 Gy) Ramos or B7" Ramos cells were added to microtiter plate wells with or without mAbs and were incubated for 7 d. All cultures were labeled for the final 18 h with 1/~Ci/well [3H]thymidine (New England Nuclear, Boston, MA) and were harvested on a 96-well plate harvester (LKB Instruments Inc., Gaithersburg, MD). Incorporated radioactivity was measured in a beta plate scintillation counter (LKB Instruments, Inc.). Each value is the mean of triplicate wells. Standard mean error of the triplicates was <10%.
lmraunofluorescence and Flow Cytoraetry. Methods of immunofluorescence and flow cytometry have been described previously (21, 22) . Flow cytometry was performed using a FACScan | or FACStar Pgus~ (Becton Dickinson Immunocytometry Systems).
Results and Discussion

CD28/B7 Costiraulates Both CD2-and CD3-dependent T Cell
Proliferation. Human B7 cDNA (23) sistent with prior findings (24), freshly isolated, small peripheral blood T cells obtained from high buoyant density lymphocytes were minimally responsive to triggering via anti-CD3. However, when T cells were stimulated by coculture with B7 + P815, but not parental P815, we observed a pronounced effect on anti-CD3-induced proliferation (Fig. 2 A) . Anti-CD3-induced proliferation costimulated by B7 + P815 was substantiaUy inhibited by anti-B7 mAb BB1 (IgM) but A not isotype-matched antioCD57 mAb Leu-7 (IgM) (Fig. 2 RAaOS 
B). Similarly, the addition of anti-CD28 F(ab')2 fragments resuhed in the inhibition of T cell proliferation (not shown).
.
7-RAaOS (-)
This indicated that the response was dependent upon the CD28/B7 interaction. Anti-CD3-induced proliferation was eT-aAaOS eel Fc dependent, in that no proliferation was observed when .7.~.os ~.-~ n T ceUs and B7 + P815 were cultured with F(ab')~ anti-CD3 fragments (Fig. 2 C) . the presence of P815. However, when resting T cells were costimulated with B7 § P815, L303 and L304 together induced significant proliferation, which was inhibited by BB1 mAb (not shown). These results suggest that the binding of B7 to CD28 costimulates both the CD3 and CD2 activation pathways.
CD28/B7 Interactions Augment Primary Allogeneic MLR.
EBV-transformed B cell lines are known to serve as potent stimulators of alloantigen-induced T cell proliferation. B lymphoblastoid cell lines have been reported to express high levels of call surface B7 (15) , suggesting the possibility that B7 expression is necessary for the generation of a primary MLR. Ramos is an EBV-negative American Burkitt's lymphoma cell line that expresses high levels of class I and II MHC antigens, but does not express B7. Preliminary experiments demonstrated that this cell line was a poor stimulator of allogeneic MLR. Ramos was transfected with B7 cDNA, and stable transfectants expressing high levels of B7 were selected. Fig. 4 shows the proliferative response of small, resting T cells from two donors cocuhured with irradiated parental Ramos and B7-transfected Ramos. Parental B7-negative Ramos failed to stimulate small, resting T cells. By contrast, small, resting T cells cocultured with B7-transfected Ramos mediated substantial proliferative responses. These proliferative responses were substantially inhibited by either BB1 or anti-CD28 F(ab')2 fragments, but not isotype-matched anti-CD57 or anti-CD16 F(ab')2 fragments.
CD28/B7 Interactions Augment CeU-mediated Cytotoacicity Triggered through CD3 and CD2. CTL clones can lyse Fc receptor-
bearing targets in the presence of anti-CD3 mAb in a "redirected" cytotoxicity assay (26) (27) (28) (29) . Unlike CTL clones, freshly isolated small resting T lymphocytes do not mediate anti-CD3 redirected lysis (29, 30) , although a small subset of CD56 § or CD57 + T cells that may represent in vivo activated T cells do mediate this function (30, 31) . Thus, en- B7-dependent antis CD3-redirected cytotaxicity, slCrlabeled P815 (0) or B7 + P815 (11) target cells were added to plates with titered amount of anti-CD3 (Leu-4) mAb. After incubation for 30 min at room temperature, freshly isohted small, resting peripheral blood T calls were added and the assay was harvested after 4 h. Results from experiments using two different T call donors (A and B) are shown. E/T ratio was 20:1.
gagement of CD3/TCK alone is insufficient to trigger a cytolytic response in the majority of resting peripheral blood T lymphocytes. It is possible that small, resting T lymphocytes lack the cellular machinery necessary for cytotoxicity. Alternatively, additional signals may be necessary to generate a cytolytic response in resting T cells that are not required for stimulation of activated T cells. The ability of combinations of hetero-bifunctional anti-CD3/antitumor and anti-CD28/ antitumor mAbs to induce cytotoxicity suggested that interaction of CD28 with its natural ligand may provide the required costimulatory signal for generation of CTL from resting peripheral blood T cells (32) . As shown in Fig. 5 , freshly isolated small resting peripheral blood T cells demonstrated potent anti-CD3-redirected cytotoxicity against B7 + P815, but not parental P815, detectable using a 4-h 5~Cr release assay. Comparable results were obtained using three independently derived B7 + P815 transfectants; however, P815 transfectants expressing high levels of CD16-II were not lysed in the presence of anti-CD3 (not shown). Lysis of B7 + P815 transfectants was inhibited by BB1 or anti-CD28 P(ab')2 fragments (Fig. 6 A) . Anti-CD3-induced cytotoxicity was Fc dependent since anti-CD3 F(ab')2 fragments failed to trigger lysis against B7 + P815 (Fig. 6 B) . mAbs against CD4 (Leu-3a), CD5 (Leu-1), CD7 (Leu-9), CD8 (Leu-2a), CDlla (L7), CD18 (L130), and CD38 (Leu-17) failed to induce redirected lysis against parental or B7 + P815 cells (not shown). However, as with the proliferative response, appropriate combinations of anti-CD2 mAb (L303 + L304) could trigger cytotoxicity against B7 + P815, but not parental P815 (Fig. 7) . Anti-CD2-induced cytotoxicity was inhibited by BB1 antibody, but not isotype-matched control mAb (not shown). These data indicate that binding of B7 to CD28 costimulates CD3/TCR-and CD2-dependent T cell-mediated cytotoxicity and demonstrates that small, resting T cells are capable of cytotoxic function.
The mechanism whereby expression of B7 on the target cell enables small, resting T cells to initiate lysis has not been defined. It is possible that the CD28/B7 interaction increases or stabilizes heterotypic cellular adhesion between the effector and target cells. However, in the present experimental system this seems unlikely since effectors and Fc receptor-bearing targets are already efficiently bridged by anti-CD3 or anti-CD2 mAbs. No obvious differences were observed in conjugate formation between parental or B7 + P815 cells and effector T cells in the presence of anti-CD3 mAb (unpublished observation). Alternatively, interaction of CD28 with B7 on the target may provide a cosignal to the T cell that is necessary to mobilize the cellular machinery necessary for cytotoxicity. Preliminary studies have indicated that cytotoxicity is unlikely to be mediated by a soluble cytotoxic factor, since no bystander cytotoxicity was observed when SlCr-labeled parental P815 cells were admixed with unlabeled B7 + P815 cells in the presence of effector T cells and anti-CD3 mAb (unpublished observation). Further studies will be necessary to elucidate the mechanism of cell-mediated cytotoxicity initiated by small, resting peripheral blood T cells. demonstrated using freshly isolated thymocyte and cord blood T cell effectors, although the activity was lower than that observed using adult small, resting T cells (Fig. 8 A) . Both small resting peripheral blood CD56-,CD4 + and CD56-, CD8 + T cells mediated equivalent levels of anti-CD3-induced cytotoxicity (Fig. 8 B) . The ability of both CD4 and CD8 T calls to mediate cytotoxicity is consistent with the ability of both CD4 and CD8 T cell clones to mediate anti-CD3-redirected cytotoxidty, demonstrating that both major subsets of T lymphocytes possess the necessary cellular components for cytolytic function ( memory T cell population is primarily responsible for this activity and both CD4 and CD8 T cells are capable of this function. It is unlikely that this cytotoxicity is mediated by in vivo activated T lymphocytes, since highly purified, small, B7-independent Cytotoxicity Mediated by T Cell Clones. The above results suggest that small, resting T ceils require CD28/B7 costimulation to induce CD2-or CD3-dependent cell-mediated cytotoxicity. In accordance with prior observations (26) (27) (28) (29) , TCR-ot/[3 + and TCR-3'/5 + CTL clones mediated anti-CD3-redirected cytotoxicity against parental P815 (Fig. 11) . Thus, while resting T cells apparently require CD28/B7 interactions to trigger cell-mediated cytotoxicity, this is no longer essential for stimulation of activated T lymphocytes. However, even with the T cell clones, we consistently observed that the presence orB7 on P815 slightly augmented cytotoxicity compared with parental P815 targets (Fig. 11) .
Effectors of CD28/BT-dependent
In summary, interaction of CD28 with its natural ligand B7 costimulates the induction of cell-mediated cytotoxicity, as well as proliferation, of small, resting T lymphocytes. Both CD2 and CD3 activation pathways cooperate with CD28 as a consequence of CD28 binding its natural ligand B7. With respect to induction of cytotoxicity, the CD45RO + resting T cells isolated by density gradient centrifugation were used for these experiments. Moreover, cytotoxicity was only observed using the B7 + P815 transfectant and not with the parental P815 cells. Since in vitro cultured CTL, as well as the presumably in vivo activated CD56 + T cells mediate redirected lysis against parental P815, it seems likely that the CD28/B7 interaction is necessary only for costimulation of small, resting T cells and is no longer required after activation. Consistent with this concept, we have previously demonstrated that TCR-qr//~ + T lymphocytes that mediate potent anti-CD3-redirected cytotoxicity downregulate CD28 expression after stimulation with Ib2 (37) . Moreover, the subset of CD28-peripheral blood T cells that coexpress CDllb in vivo are predominantly granular, low buoyant density T cells that may represent activated T cells that have undergone clonal expansion (38, 39) . Therefore, the CD28/B7 interaction may be most critical in the early generation of a ceU-mediated immune response, consistent with a possible role of CD28/B7 in the stimulation of immature thymocytes (40, 41) . The existence of functional cytolytic T cells in the small, resting T cell population may be advantageous in facilitating rapid responses to immune challenge.
